Systemic problems affecting the US natural health industry?

On May 27, 2026, the U.S. Food and Drug Administration (FDA) and Centers for Disease Control and Prevention (CDC) announced they are investigating a 3rd multistate outbreak of Salmonella infections linked to moringa powder supplements in 2026. Moringa oleifera supplements (including green powders and capsules) are heavily marketed as a “superfood” and a natural multivitamin powerhouse. They are primarily promoted for:

• Nutritional Support: Providing high concentrations of protein, iron, calcium, and vitamins A, C, and E.
• Energy & Metabolism: Boosting daily vitality and supporting healthy weight management.
• Blood Sugar & Heart Health: Helping to regulate glucose levels, lower cholesterol, and manage blood pressure.
• Immune & Inflammation Support: Using rich antioxidant content (like quercetin) to combat cellular stress and ease joint pain or chronic inflammation.

The agencies re-opened an outbreak investigation originally closed on March 17 after discovering 22 new illnesses from 4 US states. The total now stands at 119 patients across 36 states infected with Salmonella Typhimurium or Salmonella Newport strains, including 32 hospitalizations and no deaths. Illness onset dates range from August 22, 2025, to April 26, 2026.

Among 79 interviewed patients, 70 reported consuming moringa leaf powder products. The recalled product list expanded to include TNvitamins-brand Ultra Potent Complete Green Superfood Moringa capsules and Doctor’s Pride Complete Green Superfood Ultra Potent Moringa capsules distributed by Total Nutrition Inc., plus Why Not Natural Pure Organic Moringa capsules and All Live it Up-brand Super Greens dietary supplement powders.

The new investigation involves Salmonella Typhimurium infections linked to MOGO-brand moringa powder capsules distributed by MOGO Moringa LLC of St. Louis. 18 people infected with the outbreak strain have been reported from 14 states, with illness onset from February 3 to April 7, 2026. Of 8 interviewed individuals, 6 reported consuming moringa powder capsules, including 4 who specifically consumed MOGO-brand products. Seven hospitalizations occurred with no deaths reported. MOGO Moringa LLC has recalled specific lots (#15525AA EXP 6/2027 and #00926AA EXP 1/2028) of MOGO-brand Pure Moringa Oleifera capsules. The FDA is conducting traceback investigations to identify the contamination source and working with state partners to collect samples.

In April 2026, the FDA closed a separate outbreak investigation involving moringa supplements contaminated with “extensively drug-resistant” Salmonella. This outbreak linked to Rosabella-brand moringa powder capsules distributed by Ambrosia Brands LLC resulted in seven illnesses across seven states, with three hospitalizations.

Three moringa-related outbreaks in a single year underscore systemic issues affecting botanical ingredients in the global natural health industry, particularly regarding imported moringa leaf powder contamination. Health officials urge consumers who used moringa products and developed symptoms – diarrhea, abdominal cramps, fever within 12-72 hours – to seek medical attention and inform doctors about potential Salmonella exposure. Healthy adults typically remain ill for 4-7 days. Severe diarrhea may require hospitalization.

Update, 7/6/26:

Following the May 27, 2026, announcements, Total Nutrition Inc. expanded its voluntary recall on June 2 to include Lot 2748 (Exp. 07/2027) for both TNVitamins and Doctor’s Pride brands after a traceability review linked it to previously contaminated raw materials. Meanwhile, the active investigation into MOGO-brand capsules remains unchanged with 18 reported illnesses, and the FDA continues to urge consumers to check their pantries for any remaining Rosabella-brand products from the closed April outbreak. Federal and state health officials are actively working with major online platforms—including Amazon, Walmart, and TikTok Shop—to ensure all recalled moringa supplements are fully removed from the market, while reminding consumers to seek medical care if they experience Salmonella symptoms.